0001415889-23-012231.txt : 20230814 0001415889-23-012231.hdr.sgml : 20230814 20230814174959 ACCESSION NUMBER: 0001415889-23-012231 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230810 FILED AS OF DATE: 20230814 DATE AS OF CHANGE: 20230814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Atadja Peter CENTRAL INDEX KEY: 0001958563 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36020 FILM NUMBER: 231172384 MAIL ADDRESS: STREET 1: 12 PENNS TRAIL CITY: NEWTOWN STATE: PA ZIP: 18940 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Onconova Therapeutics, Inc. CENTRAL INDEX KEY: 0001130598 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 375 PHEASANT RUN CITY: NEWTOWN STATE: PA ZIP: 18940 BUSINESS PHONE: 267-759-3681 MAIL ADDRESS: STREET 1: 375 PHEASANT RUN CITY: NEWTOWN STATE: PA ZIP: 18940 FORMER COMPANY: FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS, INC. DATE OF NAME CHANGE: 20090526 FORMER COMPANY: FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS INC DATE OF NAME CHANGE: 20001226 4 1 form4-08142023_090853.xml X0508 4 2023-08-10 0001130598 Onconova Therapeutics, Inc. ONTX 0001958563 Atadja Peter C/O ONCONOVA THERAPEUTICS, INC. 12 PENNS TRAIL NEWTOWN PA 18940 true false false false 0 Stock Option (right to purchase) 1.02 2023-08-10 4 A 0 66468 0 A 2024-08-10 2033-08-10 Common Stock 66468 66468 D These options vest 100% on the first anniversary of the grant date. /s/ Mark Guerin, Attorney-in-Fact 2023-08-14